244 related articles for article (PubMed ID: 32815163)
1. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
3. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
4. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.
Prosberg M; Bendtsen F; Vind I; Petersen AM; Gluud LL
Scand J Gastroenterol; 2016 Dec; 51(12):1407-1415. PubMed ID: 27687331
[TBL] [Abstract][Full Text] [Related]
5. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
[TBL] [Abstract][Full Text] [Related]
6. The Role of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Pathogenesis of Ulcerative Colitis and Crohn's Disease.
Kurt EA; Demirci M; Ozbey D; Gareayaghi N; Eskazan T; Erzin YZ; Cakan H; Saribas S; Bal K; Kocazeybek B
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213219
[TBL] [Abstract][Full Text] [Related]
7. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
[TBL] [Abstract][Full Text] [Related]
8. Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature.
Cao Y; Shen J; Ran ZH
Gastroenterol Res Pract; 2014; 2014():872725. PubMed ID: 24799893
[TBL] [Abstract][Full Text] [Related]
9. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
[TBL] [Abstract][Full Text] [Related]
11. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
Jia W; Whitehead RN; Griffiths L; Dawson C; Waring RH; Ramsden DB; Hunter JO; Cole JA
FEMS Microbiol Lett; 2010 Sep; 310(2):138-44. PubMed ID: 20695899
[TBL] [Abstract][Full Text] [Related]
12. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P
Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the relative abundance of
Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
[No Abstract] [Full Text] [Related]
14. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
[TBL] [Abstract][Full Text] [Related]
16. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
[TBL] [Abstract][Full Text] [Related]
17. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis.
Varela E; Manichanh C; Gallart M; Torrejón A; Borruel N; Casellas F; Guarner F; Antolin M
Aliment Pharmacol Ther; 2013 Jul; 38(2):151-61. PubMed ID: 23725320
[TBL] [Abstract][Full Text] [Related]
18. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
19. Lower Level of
Zhou Y; Zhi F
Biomed Res Int; 2016; 2016():5828959. PubMed ID: 27999802
[No Abstract] [Full Text] [Related]
20. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
